This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/531194-malaysia-greenlights-moderna-covid-vaccine/

The article has changed 3 times. There is an RSS feed of changes available.

Version 1 Version 2
Malaysia greenlights Moderna Covid vaccine for conditional use as coronavirus cases climb Malaysia greenlights Moderna Covid vaccine for conditional use as coronavirus cases climb
(about 2 months later)
Malaysia’s Drug Control Authority has announced that Moderna’s Covid vaccine has been given conditional approval for usage, just as the country suffers a surge in daily coronavirus infections.Malaysia’s Drug Control Authority has announced that Moderna’s Covid vaccine has been given conditional approval for usage, just as the country suffers a surge in daily coronavirus infections.
In a statement released on Thursday, the drug regulator’s director-general, Dr Noor Hisham Abdullah, explained the decision to conditionally approve Moderna’s Spikevax was to ensure that “information on the quality, safety and effectiveness of the vaccine be monitored and evaluated based on the latest data from time to time.”In a statement released on Thursday, the drug regulator’s director-general, Dr Noor Hisham Abdullah, explained the decision to conditionally approve Moderna’s Spikevax was to ensure that “information on the quality, safety and effectiveness of the vaccine be monitored and evaluated based on the latest data from time to time.”
The director-general further added that the Ministry of Health is “committed to improving access to Covid-19 vaccine products in Malaysia.”The director-general further added that the Ministry of Health is “committed to improving access to Covid-19 vaccine products in Malaysia.”
Adding Moderna to Malaysia’s vaccine portfolio coincides with the country observing an unprecedented uptick in daily positive coronavirus infections. Over 20,500 cases on Thursday, with almost 20,000 cases recorded the day prior.Adding Moderna to Malaysia’s vaccine portfolio coincides with the country observing an unprecedented uptick in daily positive coronavirus infections. Over 20,500 cases on Thursday, with almost 20,000 cases recorded the day prior.
Alongside the conditional approval of Moderna’s Spikevax, Pfizer/BioNTech, Oxford/AstraZeneca, Johnson & Johnson’s Jansen, and Chinese Sinovac, CanSino, and Sinopharm are other vaccines rolled out in the South-East Asian country. However, Malaysia recently announced that it will stop using Sinovac once supplies run out. It says the vaccine proved to have diminished efficacy against the highly contagious Delta variant, with at least 10 fully inoculated doctors dying in Indonesia in June.Alongside the conditional approval of Moderna’s Spikevax, Pfizer/BioNTech, Oxford/AstraZeneca, Johnson & Johnson’s Jansen, and Chinese Sinovac, CanSino, and Sinopharm are other vaccines rolled out in the South-East Asian country. However, Malaysia recently announced that it will stop using Sinovac once supplies run out. It says the vaccine proved to have diminished efficacy against the highly contagious Delta variant, with at least 10 fully inoculated doctors dying in Indonesia in June.
According to data released on Wednesday, 14.7 million first doses of a coronavirus vaccine have been administered in Malaysia, with the number of second shots given standing at 7.7 million.According to data released on Wednesday, 14.7 million first doses of a coronavirus vaccine have been administered in Malaysia, with the number of second shots given standing at 7.7 million.
Since the outbreak of the pandemic, the South-East Asian country has recorded over 1.2 million coronavirus cases, with the overall Covid death-toll standing at just under 10,000 fatalities as of August 4.Since the outbreak of the pandemic, the South-East Asian country has recorded over 1.2 million coronavirus cases, with the overall Covid death-toll standing at just under 10,000 fatalities as of August 4.
If you like this story, share it with a friend!If you like this story, share it with a friend!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.